ABBOTT LABORATORIES (ABT) Executive Compensation
ABBOTT LABORATORIES (ABT) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ABT
CIK: 1800
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: IL
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerChristopher Larson
Audit LocationChicago, Illinois, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-02 | 2026-09-30 | OWNERSHIP DOCUMENT | 0001104659-26-113291 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | OWNERSHIP DOCUMENT | 0001104659-26-113287 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | OWNERSHIP DOCUMENT | 0001104659-26-113286 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | OWNERSHIP DOCUMENT | 0001104659-26-113285 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | OWNERSHIP DOCUMENT | 0001104659-26-113280 | View SEC Doc Filr Page |
| 4 | 2026-09-25 | 2026-09-23 | 4 Filing | 0001306119-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 Filing | 0001644207-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 Filing | 0001805099-26-000008 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001644207-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-25 | 4 Filing | 0001612571-26-000011 | View SEC Doc Filr Page |
| 144 | 2026-08-25 | — | 144 Filing | 0001612571-26-000008 | View SEC Doc Filr Page |
| 8-K | 2026-08-20 | 2026-08-20 | FORM 8-K | 0001104659-26-099247 | View SEC Doc Filr Page |
| 4 | 2026-08-13 | 2026-08-11 | 4 Filing | 0001867666-26-000013 | View SEC Doc Filr Page |
| 144 | 2026-08-11 | — | 144 Filing | 0001867666-26-000011 | View SEC Doc Filr Page |
| 10-Q | 2026-07-28 | 2026-06-30 | 10-Q | 0001628280-26-050134 | View SEC Doc Filr Page |
| 8-K | 2026-07-16 | 2026-07-16 | 8-K | 0001628280-26-048377 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | 4 Filing | 0001385262-26-000019 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | 4 Filing | 0001577544-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | 4 Filing | 0001879701-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | 4 Filing | 0001306119-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | 4 Filing | 0002102715-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-30 | 4 Filing | 0001867666-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-06-29 | 2026-06-27 | 4 Filing | 0002075371-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-06-18 | 2026-05-07 | 4 Filing | 0001385262-26-000017 | View SEC Doc Filr Page |
| 11-K | 2026-06-18 | 2025-12-31 | 11-K | 0001104659-26-075724 | View SEC Doc Filr Page |